相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The COVID-19 pandemic and its potential enduring impact on children
Margaret Irwin et al.
CURRENT OPINION IN PEDIATRICS (2022)
Anti-Inflammatory and Immunoregulatory Action of Sesquiterpene Lactones
Ana Paco et al.
MOLECULES (2022)
Instant determination of the artemisinin from various Artemisia annua L. extracts by LC-ESI-MS/MS and their in-silico modelling and in vitro antiviral activity studies against SARS-CoV-2
Kubra Dogan et al.
PHYTOCHEMICAL ANALYSIS (2022)
Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
Karim Farmanpour-Kalalagh et al.
FRONTIERS IN PLANT SCIENCE (2022)
Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone
Haihai Jiang et al.
FRONTIERS IN CHEMISTRY (2022)
Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants
Riadh Badraoui et al.
PHARMACEUTICALS (2022)
Identifying structural-functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation
Priyashi Rao et al.
MOLECULAR DIVERSITY (2022)
Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening
Li-chuan Zhang et al.
FUTURE MEDICINAL CHEMISTRY (2022)
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease
Haozhou Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies
Rajkumar Kulandaisamy et al.
FRONTIERS IN MICROBIOLOGY (2022)
Inhibitors of SARS-CoV-2 PLpro
Dale J. Calleja et al.
FRONTIERS IN CHEMISTRY (2022)
Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay
Anoop Narayanan et al.
COMMUNICATIONS BIOLOGY (2022)
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds
Io Antonopoulou et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal
Vitor Borges et al.
COMMUNICATIONS MEDICINE (2022)
Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature's toolbox of bioactive compounds
Io Antonopoulou et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2022)
Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors-Molecular Docking and In Vitro Study
Izabela Nawrot-Hadzik et al.
PHARMACEUTICALS (2021)
Chicory Extracts and Sesquiterpene Lactones Show Potent Activity against Bacterial and Fungal Pathogens
Suvi T. Hakkinen et al.
PHARMACEUTICALS (2021)
Anti-COVID-19 terpenoid from marine sources: A docking, admet and molecular dynamics study
Nayim Sepay et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Chicory (Cichorium intybus L.) as a food ingredient - Nutritional composition, bioactivity, safety, and health claims: A review
Jelena Perovic et al.
FOOD CHEMISTRY (2021)
Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial
Guoming Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
Structural insights into SARS-CoV-2 proteins
Rimanshee Arya et al.
JOURNAL OF MOLECULAR BIOLOGY (2021)
Characterization of the Trans-Epithelial Transport of Green Tea (C. sinensis) Catechin Extracts with In Vitro Inhibitory Effect against the SARS-CoV-2 Papain-like Protease Activity
Carmela Maria Montone et al.
MOLECULES (2021)
Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?
Dominic L. Sykes et al.
LUNG (2021)
SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome
Anna Maria Sardanelli et al.
MOLECULES (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
Jerzy Osipiuk et al.
NATURE COMMUNICATIONS (2021)
Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
Zinuo Chen et al.
CELL AND BIOSCIENCE (2021)
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras et al.
NATURE COMMUNICATIONS (2021)
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
Hylemariam Mihiretie Mengist et al.
FRONTIERS IN CHEMISTRY (2021)
Supercritical CO2 Extraction as a Tool to Isolate Anti-Inflammatory Sesquiterpene Lactones from Cichorium intybus L. Roots
Joao P. Baixinho et al.
MOLECULES (2021)
Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs
Annalisa Tito et al.
FRONTIERS IN CHEMISTRY (2021)
Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study
Manab Mandal et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Bioactivities of Phenolic Compounds from Kiwifruit and Persimmon
Young-Mo Kim et al.
MOLECULES (2021)
Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity
Carla Guijarro-Real et al.
FOODS (2021)
Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors
Daoqun Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Processing of the SARS-CoV pp1a/ab nsp7-10 region
Boris Krichel et al.
BIOCHEMICAL JOURNAL (2020)
Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV
Jared S. Morse et al.
CHEMBIOCHEM (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
Cynthia Liu et al.
ACS CENTRAL SCIENCE (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro
Ruiyuan Cao et al.
ACS INFECTIOUS DISEASES (2020)
Insights Into Dynamics of Inhibitor and Ubiquitin-Like Protein Binding in SARS-CoV-2 Papain-Like Protease
Yuliana K. Bosken et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Donghyuk Shin et al.
NATURE (2020)
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography
Daniel W. Kneller et al.
NATURE COMMUNICATIONS (2020)
Targeting Proteases for Treating COVID-19
Binquan Luan et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning
Duc Duy Nguyen et al.
CHEMICAL SCIENCE (2020)
Anti-inflammatory, antiallergic and COVID-19 protease inhibitory activities of phytochemicals from the Jordanian hawksbeard: identification, structure-activity relationships, molecular modeling and impact on its folk medicinal uses
Sherif S. Ebada et al.
RSC ADVANCES (2020)
Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale
Ahmed M. Sayed et al.
RSC ADVANCES (2020)
Inhibition of influenza virus via a sesquiterpene fraction isolated from Laggera pterodonta by targeting the NF-κB and p38 pathways
YuTao Wang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Lindenane sesquiterpenoid dimers from Chloranthus japonicus inhibit HIV-1 and HCV replication
Haan Yan et al.
FITOTERAPIA (2016)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
Sesquiterpenes from the fruits of Illicium jiadifengpi and their anti-hepatitis B virus activities
Ji-Feng Liu et al.
FITOTERAPIA (2015)
Sesquiterpene lactones: Adverse health effects and toxicity mechanisms
M. Helena R. Amorim et al.
CRITICAL REVIEWS IN TOXICOLOGY (2013)
Sesquiterpenoids Lactones: Benefits to Plants and People
Martin Chadwick et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Amino-derivatives of the sesquiterpene lactone class of natural products as prodrugs
James R. Woods et al.
MEDCHEMCOMM (2013)
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
Ji-Young Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds
CW Lin et al.
ANTIVIRAL RESEARCH (2005)
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
CN Chen et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2005)
High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
JE Blanchard et al.
CHEMISTRY & BIOLOGY (2004)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)